Literature DB >> 23105120

High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells.

Robert F Lera1, Mark E Burkard.   

Abstract

Protein kinases play key roles in regulating human cell biology, but manifold substrates and functions make it difficult to understand mechanism. We tested whether we could dissect functions of a pleiotropic mitotic kinase, Polo-like kinase 1 (Plk1), via distinct thresholds of kinase activity. We accomplished this by titrating Plk1 activity in RPE1 human epithelial cells using chemical genetics and verifying results in additional lines. We found that distinct activity thresholds are required for known functions of Plk1 including (from low to high activity) bipolar spindle formation, timely mitotic entry, and formation of a cytokinesis cleavage furrow. Subtle losses in Plk1 activity impaired chromosome congression and produced severe anaphase dysfunction characterized by poor separation of chromosome masses. These two phenotypes were separable, suggesting that they stem from distinct phosphorylation events. Impaired chromosome segregation in anaphase was the most sensitive to modest loss in Plk1 activity. Mechanistically, it was associated with unpaired sister chromatids with stretched kinetochores, suggestive of merotelic attachments. The C-terminal Polo box domain of Plk1 was required for its anaphase function, although it was dispensable for forming a bipolar spindle. The ultimate effect of partial inhibition of Plk1 was the formation of micronuclei, an increase in tetraploid progeny, and senescence. These results demonstrate that different thresholds of Plk1 activity can elicit distinct phenotypes, illustrating a general method for separating pleiotropic functions of a protein kinase even when these are executed close in time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23105120      PMCID: PMC3525009          DOI: 10.1074/jbc.M112.412544

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC.

Authors:  René H Medema; Chia-Chi Lin; James Chih-Hsin Yang
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

2.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

Review 3.  Welcome to a new kind of tension: translating kinetochore mechanics into a wait-anaphase signal.

Authors:  Thomas J Maresca; E D Salmon
Journal:  J Cell Sci       Date:  2010-03-15       Impact factor: 5.285

4.  Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.

Authors:  Sang-Moon Yun; Tinoush Moulaei; Dan Lim; Jeong K Bang; Jung-Eun Park; Shilpa R Shenoy; Fa Liu; Young H Kang; Chenzhong Liao; Nak-Kyun Soung; Sunhee Lee; Do-Young Yoon; Yoongho Lim; Dong-Hee Lee; Akira Otaka; Ettore Appella; James B McMahon; Marc C Nicklaus; Terrence R Burke; Michael B Yaffe; Alexander Wlodawer; Kyung S Lee
Journal:  Nat Struct Mol Biol       Date:  2009-07-13       Impact factor: 15.369

Review 5.  How do anti-mitotic drugs kill cancer cells?

Authors:  Karen E Gascoigne; Stephen S Taylor
Journal:  J Cell Sci       Date:  2009-08-01       Impact factor: 5.285

6.  Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.

Authors:  Aidan G Gilmartin; Maureen R Bleam; Mark C Richter; Symon G Erskine; Ryan G Kruger; Lenore Madden; Daniel F Hassler; Gary K Smith; Richard R Gontarek; Mary P Courtney; David Sutton; Melody A Diamond; Jeffrey R Jackson; Sylvie G Laquerre
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

7.  Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.

Authors:  Hongchang Li; Yun Wang; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

8.  Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation.

Authors:  Benjamin A Wolfe; Tohru Takaki; Mark Petronczki; Michael Glotzer
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

9.  Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells.

Authors:  Mark E Burkard; John Maciejowski; Verónica Rodriguez-Bravo; Michael Repka; Drew M Lowery; Karl R Clauser; Chao Zhang; Kevan M Shokat; Steven A Carr; Michael B Yaffe; Prasad V Jallepalli
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

10.  A mechanism linking extra centrosomes to chromosomal instability.

Authors:  Neil J Ganem; Susana A Godinho; David Pellman
Journal:  Nature       Date:  2009-06-07       Impact factor: 49.962

View more
  30 in total

1.  Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131).

Authors:  Ryan A Denu; Madilyn M Sass; James M Johnson; Gregory K Potts; Alka Choudhary; Joshua J Coon; Mark E Burkard
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

2.  Genotoxicity assessment of two common curing weeds: Hyptis suaveolens (L.) Poir. and Leucas indica (L.) R. Br.

Authors:  K V Sumitha; J E Thoppil
Journal:  Cytotechnology       Date:  2015-08-19       Impact factor: 2.058

Review 3.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

4.  A chemical biology strategy to analyze rheostat-like protein kinase-dependent regulation.

Authors:  Shigehiro A Kawashima; Ai Takemoto; Paul Nurse; Tarun M Kapoor
Journal:  Chem Biol       Date:  2013-02-21

Review 5.  Understanding the Polo Kinase machine.

Authors:  V Archambault; G Lépine; D Kachaner
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

6.  Plk1 protects kinetochore-centromere architecture against microtubule pulling forces.

Authors:  Robert F Lera; Roshan X Norman; Marie Dumont; Alexandra Dennee; Joanne Martin-Koob; Daniele Fachinetti; Mark E Burkard
Journal:  EMBO Rep       Date:  2019-08-30       Impact factor: 8.807

Review 7.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

8.  Scytonemin inhibits cell proliferation and arrests cell cycle through downregulating Plk1 activity in multiple myeloma cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-04-13

9.  Dynactin helps target Polo-like kinase 1 to kinetochores via its left-handed beta-helical p27 subunit.

Authors:  Ting-Yu Yeh; Anna K Kowalska; Brett R Scipioni; Frances Ka Yan Cheong; Meiying Zheng; Urszula Derewenda; Zygmunt S Derewenda; Trina A Schroer
Journal:  EMBO J       Date:  2013-03-01       Impact factor: 11.598

10.  Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.

Authors:  Benjamin Theobald; Kathy Bonness; Alla Musiyenko; Joel F Andrews; Gudrun Urban; Xizhong Huang; Nicholas M Dean; Richard E Honkanen
Journal:  Mol Cancer Res       Date:  2013-05-13       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.